Most a short while ago, it's been recognized that conolidine and the above derivatives act about the atypical chemokine receptor 3 (ACKR3. Expressed in comparable places as classical opioid receptors, it binds to some big selection of endogenous opioids. Contrary to most opioid receptors, this receptor acts to be a scavenger and won't activate a 2n